Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Porreca

Showing results (171-180 of 193) with videos related to

Pageof 20
Sort By:
BMC Cancer|January 12, 2021
Protocol of the Italian Radical Cystectomy Registry (RIC): a non-randomized, 24-month, multicenter study comparing robotic-assisted, laparoscopic, and open surgery for radical cystectomy in bladder cancerAngelo Porreca, Katie Palmer, Walter Artibani, et al.
Translational Andrology and Urology|March 15, 2021
Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancerMatteo Ferro, Marina Di Mauro, Sebastiano Cimino, et al.
Urologic Oncology|March 17, 2020
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumorMatteo Ferro, Martha Orsolya Katalin, Carlo Buonerba, et al.
Minerva Urology and Nephrology|April 4, 2025
Should every randomized controlled trial be considered Level 1 evidence?Bernardo Rocco, Maria C Sighinolfi, Alessandro Antonelli, et al.
Urologic Oncology|February 1, 2024
Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: Results from a machine learning-based analysis of a large multi-institutional databaseAnnamaria Porreca, Marta Di Nicola, Giuseppe Lucarelli, et al.
European Urology|April 28, 2023
Robot-assisted Radical Cystectomy with Orthotopic Neobladder Reconstruction: Techniques and Functional Outcomes in MalesAlberto Martini, Ugo Giovanni Falagario, Antonio Russo, et al.
Minerva Urology and Nephrology|January 13, 2021
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicenter studyMatteo Ferro, Michele Marchioni, Giuseppe Lucarelli, et al.
Clinical Genitourinary Cancer|September 4, 2023
Advanced Age Impacts Survival After Radical Nephroureterectomy for Upper Tract Urothelial CarcinomaMatteo Ferro, Sever Chiujdea, Mihai Dorin Vartolomei, et al.
European Urology Focus|February 18, 2022
The Intraoperative Complications Assessment and Reporting with Universal Standards (ICARUS) Global Surgical Collaboration Project: Development of Criteria for Reporting Adverse Events During Surgical Procedures and Evaluating Their Impact on the Postoperative CourseGiovanni E Cacciamani, Tamir Sholklapper, Paolo Dell'Oglio, et al.
Frontiers in Oncology|May 23, 2022
Robot-Assisted, Laparoscopic, and Open Radical Cystectomy: Pre-Operative Data of 1400 Patients From The Italian Radical Cystectomy RegistryGian Maria Busetto, Daniele D'Agostino, Michele Colicchia, et al.
Pageof 20

Showing results (171-180 of 193) with videos related to

Sort By:
Pageof 20
BMC Cancer|January 12, 2021
Protocol of the Italian Radical Cystectomy Registry (RIC): a non-randomized, 24-month, multicenter study comparing robotic-assisted, laparoscopic, and open surgery for radical cystectomy in bladder cancerAngelo Porreca, Katie Palmer, Walter Artibani, et al.
Translational Andrology and Urology|March 15, 2021
Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancerMatteo Ferro, Marina Di Mauro, Sebastiano Cimino, et al.
Urologic Oncology|March 17, 2020
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumorMatteo Ferro, Martha Orsolya Katalin, Carlo Buonerba, et al.
Minerva Urology and Nephrology|April 4, 2025
Should every randomized controlled trial be considered Level 1 evidence?Bernardo Rocco, Maria C Sighinolfi, Alessandro Antonelli, et al.
Urologic Oncology|February 1, 2024
Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: Results from a machine learning-based analysis of a large multi-institutional databaseAnnamaria Porreca, Marta Di Nicola, Giuseppe Lucarelli, et al.
European Urology|April 28, 2023
Robot-assisted Radical Cystectomy with Orthotopic Neobladder Reconstruction: Techniques and Functional Outcomes in MalesAlberto Martini, Ugo Giovanni Falagario, Antonio Russo, et al.
Minerva Urology and Nephrology|January 13, 2021
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicenter studyMatteo Ferro, Michele Marchioni, Giuseppe Lucarelli, et al.
Clinical Genitourinary Cancer|September 4, 2023
Advanced Age Impacts Survival After Radical Nephroureterectomy for Upper Tract Urothelial CarcinomaMatteo Ferro, Sever Chiujdea, Mihai Dorin Vartolomei, et al.
European Urology Focus|February 18, 2022
The Intraoperative Complications Assessment and Reporting with Universal Standards (ICARUS) Global Surgical Collaboration Project: Development of Criteria for Reporting Adverse Events During Surgical Procedures and Evaluating Their Impact on the Postoperative CourseGiovanni E Cacciamani, Tamir Sholklapper, Paolo Dell'Oglio, et al.
Frontiers in Oncology|May 23, 2022
Robot-Assisted, Laparoscopic, and Open Radical Cystectomy: Pre-Operative Data of 1400 Patients From The Italian Radical Cystectomy RegistryGian Maria Busetto, Daniele D'Agostino, Michele Colicchia, et al.
Pageof 20